Berkshire Aesthetics
Book Consultation

Vaginal Laxity Treatment

Non-surgical radiofrequency management of vaginal laxity and associated intimate tissue changes

Vaginal laxity is a common yet underreported condition resulting from structural changes to the vaginal canal and surrounding tissues — most frequently following vaginal delivery, hormonal decline during perimenopause and menopause, or age-related collagen loss. At Berkshire Aesthetics, our doctor-led medical assessment evaluates the nature and degree of laxity, associated symptoms and patient goals before recommending a clinically appropriate, non-surgical treatment protocol using Ultra Femme 360 radiofrequency technology.

Doctor-Led
CQC Registered
Award-Recognised
Est. 2016

Aetiology & Contributing Factors

  • Vaginal childbirth — particularly multiple or instrumental deliveries — causing stretching and micro-trauma to vaginal mucosa and supporting connective tissue
  • Oestrogen decline during perimenopause and menopause leading to mucosal atrophy, reduced collagen synthesis and loss of tissue elasticity
  • Age-related degeneration of collagen and elastin fibres within the vaginal wall and pelvic floor musculature
  • Genetic predisposition influencing connective tissue integrity and recovery capacity
  • Chronic increased intra-abdominal pressure from obesity, heavy lifting or chronic cough contributing to pelvic floor strain
  • Previous pelvic surgery or radiation therapy affecting tissue quality and vascularisation

Clinical Presentation

  • Subjective sensation of vaginal looseness or reduced tone, particularly during intercourse
  • Decreased sexual sensation or satisfaction for the patient and/or partner
  • Vaginal dryness, irritation or discomfort — especially post-menopause
  • Mild stress urinary incontinence (leaking with coughing, sneezing or exercise) due to associated pelvic floor weakness
  • Reduced confidence or avoidance of intimacy related to changes in vaginal tissue
  • Sensation of heaviness or pressure in the pelvic area (may indicate concurrent pelvic floor dysfunction)

Evidence-Based Treatment Modalities

Treatment selection is individualised following clinical assessment, taking into account disease severity, Fitzpatrick skin type, medical history and patient goals.

Ultra Femme 360

Ultra Femme 360 delivers controlled radiofrequency energy via purpose-designed internal and external applicators to stimulate neocollagenesis and tissue remodelling within the vaginal canal and vulvar tissues. The non-invasive procedure requires no anaesthesia, involves no downtime and takes approximately 8–15 minutes per session. A typical protocol involves 3 sessions spaced 1–2 weeks apart, with collagen remodelling continuing for several months post-treatment. Suitability is confirmed during a thorough, sensitive medical consultation.

Why we start with a consultation

Every treatment begins with a medical assessment. We need to understand your medical history, current health, skin condition and concerns before prescribing any procedure. This protects your safety and ensures the treatment is clinically appropriate for you.

During your consultation, Dr Langdon will explain what the treatment can realistically achieve, any risks specific to you, and whether an alternative might be more appropriate.

Book a ConsultationCall 01628 202028

All bookings are subject to our Booking Conditions.

Clinical FAQs: Vaginal Laxity

Vaginal laxity most commonly results from vaginal childbirth (particularly multiple or complex deliveries), hormonal changes during menopause causing tissue atrophy, and age-related loss of collagen and elastin in the vaginal wall. Genetic factors and chronic pelvic floor strain can also contribute.
Ultra Femme 360 delivers controlled radiofrequency energy to the vaginal and vulvar tissues, gently heating them to stimulate new collagen production (neocollagenesis) and tissue remodelling. This gradually improves tissue tone, elasticity and hydration without surgery, anaesthesia or downtime.
No. Most patients describe a comfortable warming sensation during treatment. No anaesthesia is required. The applicator is designed specifically for intimate tissue and treatment intensity is adjusted to your comfort throughout each session.
A typical protocol involves 3 treatment sessions spaced 1–2 weeks apart. Your doctor will assess your presentation and recommend an appropriate plan during your medical consultation. Maintenance sessions may be recommended every 6–12 months.
No downtime is required. You can resume normal daily activities immediately. We advise avoiding sexual intercourse, hot tubs and swimming for 48 hours following each session.
Some patients report improvement after the first session. However, collagen remodelling is a gradual biological process — optimal results typically develop over 2–3 months following completion of the treatment course as new collagen matures.
Yes. Post-menopausal vaginal changes including dryness, mucosal thinning and laxity are common indications for Ultra Femme 360. Your doctor will assess whether radiofrequency treatment is appropriate or whether additional hormonal management should be considered alongside or instead.
During your medical consultation, your doctor will assess the degree of laxity and any associated conditions such as pelvic organ prolapse. If non-surgical treatment is unlikely to achieve a meaningful clinical improvement, we will advise you honestly and discuss referral to an appropriate specialist.
Absolutely. All consultations and treatments are conducted privately and with complete discretion. Your records are held securely in accordance with medical confidentiality standards and UK data protection regulations.
Yes. For patients who also experience stress urinary incontinence or pelvic floor weakness, we may recommend combining Ultra Femme 360 with EMSella (electromagnetic pelvic floor stimulation) for a comprehensive approach to pelvic health and intimate rejuvenation.
Clinically reviewed by

Dr Selena Langdon — Medical Director, MBBS

GMC 6159259

Last reviewed:

Clinical Summary

Expected Recovery PeriodNone — Ultra Femme 360 is non-invasive with no downtime. Avoid intercourse, hot tubs and swimming for 48 hours post-treatment
Therapeutic ResponseSome improvement may be noticed after the first session; optimal results develop over 2–3 months following completion of the full treatment course as collagen remodelling matures

Clinical Governance

  • All intimate rejuvenation treatments are assessed and delivered by experienced doctors within a CQC-registered clinical environment
  • Consultations are conducted with complete sensitivity and discretion — your comfort and privacy are prioritised throughout
  • We use the clinically validated BTL Ultra Femme 360 device, specifically designed for non-surgical intimate tissue treatment
  • Honest clinical assessment — we will advise if your presentation requires gynaecological referral rather than radiofrequency treatment

Book a Consultation

Request a medical assessment for your vaginal laxity with our clinical team.

Book NowCall 01628 202028

Related Conditions

Further Reading & Clinical References

The following external resources provide independent clinical and regulatory information.

This content is for informational purposes only and does not constitute medical advice. Individual suitability for any treatment is assessed during a consultation. Always seek the guidance of a qualified medical professional with any questions regarding a medical condition or treatment.

Clinical governance

Page last reviewed: February 2026

Reviewed by Dr Selena Langdon, Medical Director (GMC 6159259) — Last reviewed: February 2026

Request a Clinical Assessment

Book a medical consultation to discuss diagnosis and an individualised treatment protocol.

Book a ConsultationCall us: 01628 202028